MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
NuVasive Cash Conversion Cycle 2011-2026 | NUVA
Annual Cash Conversion Cycle NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 406 | 398 | 404 | 417 | 375 | 400 | 368 | 360 | 339 | 304 | 331 | 411 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 417 | 304 | 376 |
Quarterly Cash Conversion Cycle NuVasive
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 430 | 436 | - | 229 | 207 | 430 | - | 395 | 436 | 450 | - | 388 | 434 | 455 | 62.2 | 436 | 434 | 421 | 62.2 | 402 | 387 | 388 | 67.4 | 418 | 411 | 400 | - | - | - | - | - | - | - | - | - | - | - | - | 50.1 | 56.5 | 57.7 | 55.4 | 49 | 54.7 | 52.6 | 53.1 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 455 | 49 | 278 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
404 | $ 88.57 | -0.65 % | $ 18 B | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Abbott Laboratories
ABT
|
101 | $ 103.99 | -0.55 % | $ 181 B | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Align Technology
ALGN
|
137 | $ 166.38 | -6.17 % | $ 12.5 B | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Alphatec Holdings
ATEC
|
240 | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
AxoGen
AXGN
|
245 | $ 31.28 | -3.01 % | $ 1.44 B | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 33.72 | -4.58 % | $ 5.02 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 69.17 | -1.43 % | $ 102 B | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
ClearPoint Neuro
CLPT
|
217 | $ 9.07 | -3.41 % | $ 257 M | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 34.58 | -5.62 % | $ 1.07 B | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Electromed
ELMD
|
180 | $ 24.55 | 0.41 % | $ 208 M | USA |
 |
Cytosorbents Corporation
CTSO
|
50.6 | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
-61.8 | $ 2.15 | -5.29 % | $ 3.36 M | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Edwards Lifesciences Corporation
EW
|
283 | $ 79.34 | -3.36 % | $ 46.4 B | USA |
 |
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | USA |
 |
Inogen
INGN
|
48.9 | $ 6.19 | -4.77 % | $ 165 M | USA |
 |
IRIDEX Corporation
IRIX
|
119 | $ 0.99 | -26.67 % | $ 16 M | USA |
 |
Integer Holdings Corporation
ITGR
|
96.8 | $ 85.33 | -1.73 % | $ 2.96 B | USA |
 |
Myomo
MYO
|
82.3 | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
352 | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
LivaNova PLC
LIVN
|
113 | $ 61.85 | -2.83 % | $ 3.37 B |  Britain |
 |
LENSAR
LNSR
|
147 | $ 6.07 | 9.96 % | $ 69.9 M | USA |
 |
Inspire Medical Systems
INSP
|
248 | $ 50.13 | -0.63 % | $ 1.47 B | USA |
 |
Medtronic PLC
MDT
|
160 | $ 87.14 | 0.21 % | $ 112 B | USA |